A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin

Clinical trial NCT07118215 · COMPLETED

Trial details

NCT number: NCT07118215
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2025-09-29
Primary completion: 2026-06-25
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.